on behalf of the IPF-PRO Registry investigators

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort”.

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

BMC Pulmonary Medicine(2020)10.1186/s12890-020-1103-4

N/A

0DataRank · unranked

106 citations

Jamie L. Todd, Richard Vinisko, Yi Liu, Megan L. Neely, Robert Overton +10 more

Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic Therapy

Lung(2024)10.1007/s00408-024-00742-x

N/A

0DataRank · unranked

4 citations

Stefan Bentink, Christian Heßlinger, Thomas B. Leonard, Megan L. Neely, Nina Patel +6 more